Lucida Medical

Lucida Medical

Private
CambridgeHealthcare & Life Scienceshttps://lucidamedical.com

Last Round

Early Funding

Mar 30, 2026

Total Funding Raised

$14.72M

Momentum Score

75 /100

Company Overview

Lucida Medical is a healthcare technology company that develops artificial intelligence-based software to assist clinicians in detecting and diagnosing cancer using MRI scans.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Precision Medicine

Business Model

B2G

Customer Profile

Subscription SaaS, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

prostate AIradiology AImedical imaging AIAI cancer detectionprostate MRI analysisclinical decision supportbiopsy avoidancemedical device softwarePACS integrationPI-RADS supportAI prostate segmentationCE marked softwareNHS AI supplier

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lucida Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lucida Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 30, 2026
GrantJul 9, 2024
GrantFeb 12, 2024
SeedMar 19, 2021

Key People

Founding team and executive leadership

Antony Rix

CEO And Co-Founder

Founding Team

Mark Hinton

Chief Technology Officer

Executive Team

Lucida Medical Investors

Notable investors and investment history

InvestorRounds
SBRI HealthcareGrant
IW CapitalEarly Funding
Prostate Cancer ResearchSeed
XTX VenturesEarly Funding, Seed
Macmillan Cancer SupportEarly Funding, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors increased 42% to 7,000.

  • Apr 7, 2026

    Lucida Medical is developing a patented AI software designed to support earlier and more consistent cancer detection.

Lucida Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lucida Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lucida Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range30
Year Founded2019
Last FundingMar 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.